| Clinical study "common" name (formal title) | Number of enrollees (per protocol [PP]/intent-to-treat [ITT]) | Funding source (pharmaceutical company/National Institutes of Health [NIH]) | Year completed | Primary publication | Full study treatment protocol |
|---|---|---|---|---|---|
|
MYRROR (Intravitreal Aflibercept Injection in Patients With Myopic Choroidal Neovascularization: The MYRROR Study) |
N=122 | Bayer/Regeneron (NCT01249664) | 41487 | Ikuno Y, et al. Intravitreal aflibercept injection in patients with myopic choroidal neovascularization: The MYRROR Study. Ophthalmology. 2015;122(6):1220-1227. https://www.aaojournal.org/article/S0161-6420(15)00098-6/fulltext |
|